- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gland Pharma Limited — Updates, 07-01-2026: Press Release
07-01-2026 | 03:40 pm
07-01-2026 | 03:40 pm
Gland Pharma secured USFDA approval for its Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). This generic drug, therapeutically equivalent to Alcon's Pataday, treats ocular itching, opening a new market for the company in the US.
No comments yet. Be the first to comment!